➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Dow
AstraZeneca
Mallinckrodt
Merck

Last Updated: October 28, 2020

DrugPatentWatch Database Preview

Claims for Patent: 7,993,249

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,993,249
Title:Swing enhancement exercise device with resilient resistance
Abstract: A training and swing exercise device with resilient resistance is used as a training apparatus for developing greater power and strength at impact when striking a ball. The device provides impact resistance to a golfer, baseball player\'s, hockey player\'s, field hockey player\'s and tennis player\'s swing in order to develop greater strength and power at ball impact. The striking unit which pivots provides high impact absorption.
Inventor(s): Fassl; Michael J. (New Egypt, NJ), Kaiser; Robert T. (South Hampton, NJ)
Assignee:
Application Number:11/527,065
Patent Claims:1. A swing exercise device for developing greater power and strength at impact when striking a ball with a bat and thus condition and train a user's swing comprising: a support frame having a base and an outrigger arm; a strike element suspended by a support shaft from the outrigger arm, the strike element having a padded energy absorbing surface; the support shaft is attached to the outrigger arm by a pivot, the strike element is pivotally suspended by the support shaft from the outrigger arm; at least one resilient element coupled between the outrigger arm of the support frame and the support shaft; the strike element including indicia of balls at various heights marking desired range of impact areas; and a removably attached home plate, wherein the home plate is attached to the support frame with a telescoping section, wherein the user swings and impacts the strike element and the support shaft rotates about the pivot causing the resilient element to be extended for exerting force against the swing which is proportional to the strength of the swing; whereby the impact is dampened by the padded energy absorbing surface and movement of the suspended strike element is resisted by the at least one resilient element.

Details for Patent 7,993,249

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial 2025-11-01 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Express Scripts
AstraZeneca
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.